{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T06:30:33Z","timestamp":1777789833635,"version":"3.51.4"},"reference-count":19,"publisher":"SAGE Publications","issue":"4","license":[{"start":{"date-parts":[[1995,10,1]],"date-time":"1995-10-01T00:00:00Z","timestamp":812505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Biol Markers"],"published-print":{"date-parts":[[1995,10]]},"abstract":"<jats:p>The Prostate-Specific Antigen (PSA) and the Cancer-Associated Serum Antigen (CASA) assay for the MUC1 mucin were compared in the serum of 303 patients with malignant or benign prostatic disease. Using cutpoints of 4, 10, and 20 \u03bcg\/l, PSA was elevated in 93%, 81%, and 64% of patients with prostate cancer (n = 113), with corresponding specificities of 55%, 84%, and 96% in benign prostate disease (prostatic hyperplasia or prostatitis, n = 190). Using the recommended cutpoint of 4 Units\/ml, CASA was elevated in 38% of patients with prostate cancer, with a specificity of 91% in benign disease. PSA and CASA showed a poor correlation in prostate cancer (r = 0.367) and benign disease (r = 0.158), and CASA was elevated in some PSA negative samples. Used together, PSA \u226520 \u03bcg\/l and CASA \u22654 kU\/l gave perfect specificity in benign disease, with a corresponding sensitivity of 29% (positive and negative predictive values of 100% and 70%, respectively). However, this combination gave no improvement over the use of PSA alone, with sensitivity 47% when the cutpoint was raised to give perfect specificity. These data suggest that CASA is of little use as an adjunct to PSA in the differentiation of benign and malignant prostate disease.<\/jats:p>","DOI":"10.1177\/172460089501000406","type":"journal-article","created":{"date-parts":[[2018,3,13]],"date-time":"2018-03-13T13:58:12Z","timestamp":1520949492000},"page":"221-225","source":"Crossref","is-referenced-by-count":4,"title":["Prostate-specific Antigen (PSA) and Cancer-Associated Serum Antigen (CASA) in Distinguishing Benign and Malignant Prostate Disease"],"prefix":"10.1177","volume":"10","author":[{"given":"P.L.","family":"Devine","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynaecology, University of Queensland, Queensland - Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.D.","family":"Walsh","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Queensland, Queensland - Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. A.","family":"McGuckin","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, University of Queensland, Queensland - Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. J.","family":"Quin","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, University of Queensland, Queensland - Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B. G.","family":"Hohn","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Queensland, Queensland - Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Clague","sequence":"additional","affiliation":[{"name":"Department of Chemical Pathology, Royal Brisbane Hospital, Queensland - Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Samaratunga","sequence":"additional","affiliation":[{"name":"Department of Anatomical Pathology, Royal Brisbane Hospital, Queensland - Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[1995,10,1]]},"reference":[{"key":"bibr1-172460089501000406","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199104253241702"},{"key":"bibr2-172460089501000406","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1001\/jama.1992.03480160094042","volume":"267","author":"Osterling J.E.","year":"1992","journal-title":"JAMA"},{"key":"bibr3-172460089501000406","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19930201)71:3+<891::AID-CNCR2820711405>3.0.CO;2-X"},{"key":"bibr4-172460089501000406","first-page":"327","volume":"39","author":"Drago J.R.","year":"1989","journal-title":"CA-"},{"key":"bibr5-172460089501000406","doi-asserted-by":"publisher","DOI":"10.1016\/0090-4295(89)90100-3"},{"key":"bibr6-172460089501000406","doi-asserted-by":"publisher","DOI":"10.1093\/clinchem\/38.5.735"},{"key":"bibr7-172460089501000406","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)37398-6"},{"key":"bibr8-172460089501000406","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19930915)72:6<2007::AID-CNCR2820720636>3.0.CO;2-U"},{"key":"bibr9-172460089501000406","first-page":"9","volume":"6","author":"Layton G.T.","year":"1991","journal-title":"J Tumor Marker Oncol"},{"key":"bibr10-172460089501000406","doi-asserted-by":"publisher","DOI":"10.1016\/S0001-2998(78)80014-2"},{"key":"bibr11-172460089501000406","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19940901)74:5<1615::AID-CNCR2820740520>3.0.CO;2-6"},{"key":"bibr12-172460089501000406","doi-asserted-by":"publisher","DOI":"10.1016\/0009-8981(93)90106-E"},{"key":"bibr13-172460089501000406","doi-asserted-by":"publisher","DOI":"10.1155\/1993\/192831"},{"key":"bibr14-172460089501000406","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910440423"},{"key":"bibr15-172460089501000406","first-page":"11","volume":"5","author":"Devine P.L.","year":"1990","journal-title":"J Tumor Marker Oncol"},{"key":"bibr16-172460089501000406","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19930115)71:2<430::AID-CNCR2820710225>3.0.CO;2-S"},{"key":"bibr17-172460089501000406","doi-asserted-by":"publisher","DOI":"10.1046\/j.1525-1438.1992.02030119.x"},{"key":"bibr18-172460089501000406","first-page":"221","volume":"13","author":"Devine P.L.","year":"1993","journal-title":"Cancer Biochem Biophys"},{"key":"bibr19-172460089501000406","first-page":"1129","volume":"4","author":"Devine P.L.","year":"1994","journal-title":"Int J Oncol"}],"container-title":["The International Journal of Biological Markers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/172460089501000406","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/172460089501000406","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T19:58:14Z","timestamp":1777492694000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/172460089501000406"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,10]]},"references-count":19,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1995,10]]}},"alternative-id":["10.1177\/172460089501000406"],"URL":"https:\/\/doi.org\/10.1177\/172460089501000406","relation":{},"ISSN":["0393-6155","1724-6008"],"issn-type":[{"value":"0393-6155","type":"print"},{"value":"1724-6008","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,10]]}}}